Simone Mathoulin-Pelissier
Overview
Explore the profile of Simone Mathoulin-Pelissier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Frasca M, Sabathe C, Delaloge S, Galvin A, Patsouris A, Levy C, et al.
Eur J Cancer
. 2020 Aug;
137:240-249.
PMID: 32805641
Introduction: Patients with metastatic breast cancer (MBC) often require inpatient palliative care (IPC). However, mounting evidence suggests age-related disparities in palliative care delivery. This study aimed to assess the cumulative...
32.
Auzanneau C, Bacq D, Bellera C, Blons H, Boland A, Boucheix M, et al.
ESMO Open
. 2020 Jul;
5(4).
PMID: 32713836
Background: Whole exome sequencing and RNA sequencing (WES/RNASeq) should now be implemented in the clinical practice in order to increase access to optimal care for cancer patients. Providing results to...
33.
Frasca M, Galvin A, Raherison C, Soubeyran P, Burucoa B, Bellera C, et al.
BMJ Support Palliat Care
. 2020 Jul;
11(2):188-199.
PMID: 32680891
Background: Guidelines recommend an early access to specialised palliative medicine services for patients with cancer, but studies have reported a continued underuse. Palliative care facilities deliver early care, alongside antineoplastic...
34.
Le Morvan V, Richard E, Cadars M, Fessart D, Broca-Brisson L, Auzanneau C, et al.
Br J Cancer
. 2020 Jun;
123(5):772-784.
PMID: 32565541
Background: Cytochrome P450 1B1 (CYP1B1) is mostly expressed in tumours and displays unusual properties. Its two polymorphic forms were differently associated with anticancer drug sensitivity. We decipher here the role...
35.
Foucan A, Grosclaude P, Bousser V, Bauvin E, Smith D, Andre-Fardeau C, et al.
Clin Res Hepatol Gastroenterol
. 2020 May;
45(2):101413.
PMID: 32359832
Background: The care management of colorectal cancers has evolved, particularly since the implementation of multidisciplinary team meetings (MDTm). The aim of this study was to identify factors associated with the...
36.
Amadeo B, Penel N, Coindre J, Ray-Coquard I, Ligier K, Delafosse P, et al.
BMC Cancer
. 2020 Mar;
20(1):190.
PMID: 32138705
Background: The exhaustive collection of new sarcoma cases and their second histologic review offer a unique opportunity to study their incidence and time trends in France according to the major...
37.
Deluche E, Antoine A, Bachelot T, Lardy-Cleaud A, Dieras V, Brain E, et al.
Eur J Cancer
. 2020 Mar;
129:60-70.
PMID: 32135312
Aim: Real-world data inform the outcome comparisons and help the development of new therapeutic strategies. To this end, we aimed to describe the full characteristics and outcomes in the Epidemiological...
38.
Italiano A, Mir O, Mathoulin-Pelissier S, Penel N, Piperno-Neumann S, Bompas E, et al.
Lancet Oncol
. 2020 Feb;
21(3):446-455.
PMID: 32078813
Background: Patients with Ewing sarcoma or osteosarcoma have a median overall survival of less than 12 months after diagnosis, and a standard treatment strategy has not yet been established. Pharmacological...
39.
Lerebours F, Pulido M, Fourme E, Debled M, Becette V, Bonnefoi H, et al.
Br J Cancer
. 2020 Feb;
122(6):759-765.
PMID: 32001832
Background: Few data are available on survival and predictive factors in early breast cancer (BC) patients treated with neoadjuvant endocrine therapy (NET). Methods: This is a pooled analysis of two...
40.
Villa A, Molimard M, Bignon E, Martinez B, Rouyer M, Mathoulin-Pelissier S, et al.
BMJ Open
. 2019 Nov;
9(11):e033040.
PMID: 31712349
Introduction: Antineoplastic drugs (AD) are potentially carcinogenic and/or reprotoxic molecules. Healthcare professionals are increasingly exposed to these drugs and can be potentially contaminated by them. Internal contamination of professionals is...